ZEISS Medical Technology announced that China's National Medical Products Administration (NMPA) has approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes provide high-quality optical and digital visualisation for both anterior and posterior segments. With upgrades spanning both hardware and software, the newly approved microscopes supporting ophthalmic surgeries ensure more precise operations and greater surgical safety with enhanced resolution, RGB illumination and full compatibility with the latest generation of ZEISS's cataract workflow.

"The introduction of ZEISS ARTEVO 750 and ARTEVO 850 microscopes powerfully demonstrates our commitment to ophthalmologists in China. We will leverage the power of innovation to contribute to the advancement of eye health in China and better serve Chinese surgeons and their patients," says Martin Fischer, President & CEO of ZEISS Greater China.

The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE). Combining advanced technology with established optical expertise, the ARTEVO 750 enables surgeons to finetune their surgical views in routine and complex procedures, including cataract & vitreoretinal surgery, corneal transplantation, and minimally invasive glaucoma surgery (MIGS). With enhanced resolution, elevated depth of field, intelligent RGB illumination and intraoperative OCT, the ZEISS ARTEVO 750 supports excellent usability and a seamless end-to-end workflow.

"The enhanced optical resolution of the ARTEVO 750 enables us to elevate our capabilities in performing delicate ophthalmic surgeries," states Professor Chen Jili from Shanghai Jing'an District Shibei Hospital.